Picture of Epigenomics AG logo

ECX — Epigenomics AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Epigenomics FY Net Loss Widens To EUR 12.7 Million

March 27 (Reuters) - Epigenomics AG  ECXn.DE :
    * FY TOTAL REVENUE OF EUR 1.5 MILLION AND EBITDA (BEFORE
SHARE-BASED PAYMENT EXPENSES) OF EUR -11.4 MILLION
    * FY NET LOSS FOR YEAR TO EUR -12.7 MILLION (2017: EUR -10.2
MILLION).
    * FOR 2019, WE EXPECT EBITDA BEFORE SHARE-BASED PAYMENT
EXPENSES
TO REMAIN UNCHANGED FROM PREVIOUS YEAR'S GUIDANCE IN A RANGE OF
EUR -11.5 MILLION TO EUR -14.0 MILLION.
    * COMPANY EXPECTS REVENUE 2019 WITHIN RANGE OF EUR 3.0
MILLION TO
EUR 6.0 MILLION EVEN WITHOUT MEDICARE COVERAGE

Source text for Eikon:  ID:nEQ1YqhHYa 
Further company coverage:  ECXn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Epigenomics AG

See all news